1. |
Nair GB, Niederman MS. Updates on community acquired pneumonia management in the ICU. Pharmacol Ther. 2021;217: 107663.
|
2. |
Saklayen MG. The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep. 2018;20(2): 12.
|
3. |
Szilveszter M, Pál S, Simon-Szabó Z, et al. The Management of COVID-19-Related Coagulopathy: A Focus on the Challenges of Metabolic and Vascular Diseases. Int J Mol Sci. 2023;24(16): 12782.
|
4. |
Smith M, Honce R, Schultz-Cherry S. Metabolic Syndrome and Viral Pathogenesis: Lessons from Influenza and Coronaviruses. Journal of Virology. 2020;94(18).
|
5. |
中华医学会呼吸病学分会. 中国成人社区获得性肺炎诊断和治疗指南(2016年版). 中华结核和呼吸杂志, 2016, 39(4): 253-279.
|
6. |
中华医学会糖尿病学分会代谢综合征研究协作组. 中华医学会糖尿病学分会关于代谢综合征的建议. 中华糖尿病杂志, 2004(3): 5-10.
|
7. |
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA, 2001, 285(19): 2486-2497.
|
8. |
Venet F, Monneret G. Advances in the understanding and treatment of sepsis-induced immunosuppression. Nat Rev Nephrol, 2018, 14(2): 121-137.
|
9. |
Shimabukuro-Vornhagen A, Gödel P, Subklewe M, et al. Cytokine release syndrome. J Immunother Cancer, 2018, 6(1): 56.
|
10. |
Cavallazzi R, Furmanek S, Arnold FW, et al. The Burden of Community-Acquired Pneumonia Requiring Admission to ICU in the United States. Chest. 2020, 158(3): 1008-1016.
|
11. |
Grandl G, Wolfrum C. Hemostasis, endothelial stress, inflammation, and the metabolic syndrome. Semin Immunopathol. 2018, 40(2): 215-224.
|
12. |
Qiu L, Gao C, Wang H, et al. Effects of dietary polyphenol curcumin supplementation on metabolic, inflammatory, and oxidative stress indices in patients with metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials. Front Endocrinol (Lausanne). 2023, 14: 1216708.
|
13. |
Yao F, Bo Y, Zhao L, et al. Prevalence and Influencing Factors of Metabolic Syndrome among Adults in China from 2015 to 2017. Nutrients. 2021, 13(12): 4475.
|
14. |
Wang J, Zhu L, Liu L, et al. Clinical features and prognosis of COVID-19 patients with metabolic syndrome: A multicenter, retrospective study. Med Clin (Barc), 2022, 158(10): 458-465.
|
15. |
Steenblock C, Schwarz PEH, Ludwig B, et al. COVID-19 and metabolic disease: mechanisms and clinical management. The Lancet Diabetes & Endocrinology. 2021, 9(11): 786-798.
|
16. |
Diabetes Canada Clinical Practice Guidelines Expert Committee, Punthakee Z, Goldenberg R, et al. Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome. Can J Diabetes. 2018, 42 Suppl 1: S10-S15.
|
17. |
Chen Y, Xu W, Zhang W, et al. Plasma metabolic fingerprints for large-scale screening and personalized risk stratification of metabolic syndrome. Cell Rep Med. 2023, 4(7): 101109.
|
18. |
Nisar M, Iqbal MUN. Influence of hs-CRP, IL-6 and TNF-α and it’s role in dyslipidemia and type 2 diabetes in population of Karachi, Pakistan. Pak J Pharm Sci. 2021, 34(3(Special)): 1217-1225.
|
19. |
Berbudi A, Rahmadika N, Tjahjadi AI, et al. Type 2 Diabetes and its Impact on the Immune System. Curr Diabetes Rev. 2020;16(5):442-449.
|
20. |
Sakr HF, Sirasanagandla SR, Das S, et al. Insulin Resistance and Hypertension: Mechanisms Involved and Modifying Factors for Effective Glucose Control. Biomedicines, 2023, 11(8): 2271.
|
21. |
Aslan Çin NN, Yardımcı H, Koç N, et al. iglycerides/high-density lipoprotein cholesterol is a predictor similar to the triglyceride-glucose index for the diagnosis of metabolic syndrome using International Diabetes Federation criteria of insulin resistance in obese adolescents: a cross-sectional study. J Pediatr Endocrinol Metab, 2020, 24,33(6): 777-784.
|